Skip to content

The effectiveness of recovery-oriented cognitive therapy with and without cognitive remediation in individuals with schizophrenia disorder.

The effectiveness of recovery-oriented cognitive therapy with and without cognitive remediation in individuals with schizophrenia disorder.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200701047974N1
Enrollment
30
Registered
2020-07-02
Start date
2020-07-22
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia disorder. Schizophrenia

Interventions

Intervention 1: Intervention group1: Intervention groups A will undergo recovery oriented cognitive therapy (CT-R). The program is designed to run individually or in groups, and will run for 14 sessi

Sponsors

University of social welfare and rehabilitation sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 20-60 years Diagnosis of schizophrenia based on DSM-5 criteria At least two years have passed since the onset of schizophrenia and most of the symptoms are negative. The score of positive and negative symptoms of the patient in SAPS tests (positive symptom assessment scale) and SANS (negative symptom evaluation scale) should be above the cutting point of 35 and 24, respectively. Ability to reading and writing

Exclusion criteria

Exclusion criteria: Brain damage, mental retardation, physical disability that interferes with the assessment process. Neurological disease (epilepsy, Alzheimer's, dementia, Parkinson's, MS, etc.) due to which the person being under treated The patient is seriously affected by the side effects of psychiatric medications that interfere with the study process. Dissatisfaction with participating in the study The patient is in the acute phase of the disease Receive an electroshock at least 6 months before the study and during treatment Be currently undergoing other psychological interventions The patient is severely affected by abuse, poisoning or deprivation of any kind of drug (smoking is not considered a exclusion criterion ).

Design outcomes

Primary

MeasureTime frame
Negative Symptoms. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Scale for Assessment of Negative Symptoms (SANS).;Positive Symptoms. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Scale for Assessment of Positive Symptoms (SAPS).;Neurocognitive impairment. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: MATRICES.;Dysfunctional Attitude. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Dysfunctional Attitude Scale (DAS).;Real-World Functioning. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: WHO DAS .2.;Quality of life. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Self-report quality of life measure for people with schizophrenia.;Mental Health Recovery. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Mental Health Recovery Measure.;Recovery. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Recovery Self-Assessment–Revised (RSA-R).;Hope. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: The Schizophrenia Hope Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Ebrahimi

University of social welfare and rehabilitation sciences

Alipsychologist69@gmail.com+98 21 2218 0083

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026